https://www.selleckchem.com/pr....oducts/sulfatinib.ht
Thrombocytopenia (platelet count 150×10³/μL) is associated with poor outcomes in various critical illness settings. However, the prognostic value of platelet count in patients with cardiogenic shock (CS) remains unclear. We enrolled 1202 patients between January 2014 and December 2018 from a multicenter retrospective-prospective cohort registry of CS. Clinical characteristics and treatment outcomes were compared between the patients with and without thrombocytopenia. At presentation with CS, 244 (20.3%) patients had thrombocytope
Like
Comment
Share
